Investigating the role of omega-3 fatty acids in treating nerve damage from diabetes
Official title: Omega-3 Polyunsaturated Fatty Acids in the Treatment of Diabetic Peripheral Neuropathy:Is the source important?
Funded at Iowa City VA Medical Center · NIH-10854778 · Data updated 2026-11-12
This study is looking at whether omega-3 fatty acids, like those found in fish oil, can help repair nerve damage in veterans with type 2 diabetes who have diabetic peripheral neuropathy, and it hopes to find new ways to improve their nerve health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iowa City VA Medical Center NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project start | July 1, 2021 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| NIH project number | 5I01RX003826-04 |
| Project ID | NIH-10854778 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with type 2 diabetes who are experiencing symptoms of diabetic peripheral neuropathy.
✕Less likely to help
Patients without diabetes or those who do not have diabetic peripheral neuropathy may not benefit from this research.
What this research studies
This research focuses on the potential of omega-3 polyunsaturated fatty acids (PUFAs) to repair nerve damage caused by diabetic peripheral neuropathy (DPN), particularly in veterans with type 2 diabetes. The study aims to determine whether the source of omega-3s, such as fish oil, influences their effectiveness in promoting nerve repair. By examining the anti-inflammatory and neuroprotective properties of specific omega-3 metabolites, the research seeks to establish a new treatment pathway for DPN, which currently has limited options. Patients may be involved in clinical trials that assess the impact of these fatty acids on their nerve health.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option for patients suffering from diabetic peripheral neuropathy, potentially improving their quality of life.
How similar studies have gone: Previous studies have shown promising results with omega-3 fatty acids in animal models, but this research aims to explore their effectiveness in human patients, making it a novel approach.
Where this research is happening
-
Iowa City VA Medical Center
Iowa City, United States Active
Researchers
- Principal investigator: Yorek, Mark a. — Iowa City VA Medical Center
- Study coordinator: Yorek, Mark a.
Related research
Other NIH-funded projects on the same topics.
-
Gut bacterial vesicles and diabetic nerve damage
This work looks at whether tiny particles released by gut bacteria can protect nerves and ease numbness and pain in people with diabetic peripheral neuropathy.
-
Restoring sensation in amputated limbs for veterans with diabetic neuropathy
This study is looking to help veterans who have lost lower limbs due to diabetic peripheral neuropathy by using special electrodes to create sensations that feel like they're coming from their missing foot, which could improve their daily activities and overall limb health.
-
Wearable vibration to improve movement and reduce pain in diabetic nerve damage
A wearable vibration device is tested for four weeks to help adults with diabetic peripheral neuropathy walk better and experience less pain.
-
Improving walking and reducing foot pressure for people with diabetic nerve damage
This project tries real-time biofeedback to change how adults with diabetic peripheral neuropathy walk so they have lower harmful foot pressure and better walking speed.
-
Exploring how gut bacteria affect nerve damage in diabetes
This study is looking at how tiny particles from gut bacteria might help protect nerves in people with diabetic peripheral neuropathy, which is a common issue for those with diabetes, and it hopes to find new ways to improve nerve health through better gut health.
-
Investigating how tau phosphorylation affects nerve damage in diabetes
This study is looking into how problems with insulin and a protein called tau affect nerve health in people with Type 1 Diabetes, with the hope of finding new ways to ease the pain and improve life for those dealing with diabetic nerve issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.